79 related articles for article (PubMed ID: 1734235)
1. The correlation between lupus anticoagulant and autoantibodies.
Gleicher N; Harlow L; el-Roeiy A
Mt Sinai J Med; 1992 Jan; 59(1):32-7. PubMed ID: 1734235
[TBL] [Abstract][Full Text] [Related]
2. Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations.
Gleicher N; Harlow L
Mt Sinai J Med; 1990 Sep; 57(4):242-8. PubMed ID: 2123297
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women.
el-Roeiy A; Myers SA; Gleicher N
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):390-6. PubMed ID: 2106107
[TBL] [Abstract][Full Text] [Related]
4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
5. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.
el-Roeiy A; Gleicher N; Isenberg D; Kennedy RC; Shoenfeld Y
Clin Exp Immunol; 1987 Jun; 68(3):528-34. PubMed ID: 3115649
[TBL] [Abstract][Full Text] [Related]
6. Is endometriosis an autoimmune disease?
Gleicher N; el-Roeiy A; Confino E; Friberg J
Obstet Gynecol; 1987 Jul; 70(1):115-22. PubMed ID: 3110710
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
8. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
9. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Pengo V; Biasiolo A; Rampazzo P; Brocco T
Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
[TBL] [Abstract][Full Text] [Related]
10. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
11. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization.
el-Roeiy A; Gleicher N; Friberg J; Confino E; Dudkiewicz A
Obstet Gynecol; 1987 Aug; 70(2):163-70. PubMed ID: 3601277
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of various ELISA assays for detecting antiphospholipid antibodies.
Falcón CR; Hoffer AM; Forastiero RR; Carreras LO
Thromb Haemost; 1990 Aug; 64(1):21-5. PubMed ID: 2125755
[TBL] [Abstract][Full Text] [Related]
13. Partial neutralization of a lupus anticoagulant by human immunoglobulin.
Carreras LO; Pérez GN; Martinuzzo ME; Malan-Borel I; Malbrán A; Said PB
Thromb Haemost; 1990 Aug; 64(1):32-7. PubMed ID: 2125757
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
[TBL] [Abstract][Full Text] [Related]
15. The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation--reduction reactions.
McIntyre JA
Thromb Res; 2004; 114(5-6):579-87. PubMed ID: 15507294
[TBL] [Abstract][Full Text] [Related]
16. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to factor XII associated with lupus anticoagulant.
Jones DW; Gallimore MJ; Harris SL; Winter M
Thromb Haemost; 1999 Mar; 81(3):387-90. PubMed ID: 10102466
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
